Moderate Concern

Your Assessment: Your OTC Medication Use Shows a Concerning Pattern

Your answers suggest your use of over-the-counter medication has moved beyond occasional, as-needed use into a pattern that could indicate developing dependency. This isn’t unusual – and it’s nothing to be ashamed of – but it does need attention.

What your answers suggest

One or more of the following applies: you’re using the product more frequently than intended, you’re using it for reasons beyond its designed purpose (e.g. to cope, relax, or sleep when you’re not actually ill), you’ve found it harder to stop than expected, or it’s starting to affect your daily life.

How OTC dependency develops

It follows the same pathway as any substance dependency:

1. Regular use creates tolerance. The product works less well, so you take it more often or at higher doses.
2. Your body adapts. Without it, you feel worse than before you started – rebound symptoms (pain, insomnia, anxiety) are common.
3. Psychological reliance. You begin to feel you can’t cope, sleep, or function without it.
4. The cycle deepens. Stopping becomes harder over time, not easier.

The fact that these are pharmacy products doesn’t make the dependency less real. Codeine is an opioid. Promethazine is a sedative. These are pharmacologically active drugs.

What we’d recommend

Call our advice line. We understand OTC medication dependency and can advise you on the safest way to reduce. For codeine-containing products in particular, a structured reduction plan is much safer than going cold turkey.

Be honest about how much you’re using. Many people minimise their OTC use, even to themselves. Tracking your actual intake for one week can be revealing.

Check for hidden ingredients. Many OTC products contain paracetamol. If you’re exceeding the recommended dose or combining products, your liver may be at risk.

We can help

A brief, confidential call with our team can help you understand whether professional support would benefit you – and what that looks like in practice.